When to Consider Starting Metformin – with Alex Lazo-Vasquez, MD
Timeline
Video Summary
The interview explores when metformin may be considered as part of metabolic health management. Insulin resistance, glucose control, and early risk indicators are discussed. The physician explains why timing and patient selection matter. Metformin is framed as a tool, not a default solution.
Clinical criteria for starting metformin are examined in detail. Lab markers, patient history, and lifestyle factors are emphasized. The discussion highlights benefits such as improved insulin sensitivity. Limitations and contraindications are also addressed.
Practical considerations conclude the interview. Monitoring strategies, side effects, and long-term planning are discussed. Individualized decision making is reinforced as the safest approach. Education supports informed patient choices.
Drug Callouts
Condition Callouts
Key Takeaways
- Metformin is not a default therapy.
- Timing and patient selection matter.
- Lab markers guide treatment decisions.
- Monitoring and education improve outcomes.
- Individualized care is essential.